Stentys €40m rights issue lets FSI and funds in
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Equity

Stentys €40m rights issue lets FSI and funds in

Stentys, a biotechnology company with a focus on heart problems, launched a €36.4m rights issue on Tuesday, which will allow for a reorganisation of shareholders with the French Fonds Stratégique d’Investissement (FSI) joining the register.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article